Overexpression of GLIPR1 in prostate, bladder and lung cancer, as well as osteosarcoma cells, has been demonstrated to reduce tumour cell proliferation and/or colony formation in vitro [24, 25, 27, 29]. Here, GLIPR1 is linked to neoplasm.